China has launched new Alzheimer’s drug

China has publicised new drug to treat Alzheimer’s disease has hit the market, raising hopes of a cure for millions of people in the country and abroad suffering from the brain disorder. Extracted from brown algae, the medicine is said to be the world’s first innovative therapy for the treatment of Alzheimer’s disease in 17 years.

Daily Current Affairs Quiz 2020

The drug named GV-971, which was officially approved on November 2, is now available in the domestic market with the price of 40,000 yuan ($5,700) for a patient per annum. Alzheimer’s disease, which mostly affects elderly people, is regarded as an incurable, irreversible and progressive brain disorder that slowly destroys memory, thinking ability and the capability to carry out simple tasks. The drug provides new choices to patients with Alzheimer’s and continued research will be conducted on its long-term effects and safety.